These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 3469935

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Monotherapy for empiric treatment of fever in granulocytopenic cancer patients.
    Wade JC, Johnson DE, Bustamante CI.
    Am J Med; 1986 May 30; 80(5C):85-95. PubMed ID: 3521273
    [Abstract] [Full Text] [Related]

  • 24. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Cometta A, Zinner S, de Bock R, Calandra T, Gaya H, Klastersky J, Langenaeken J, Paesmans M, Viscoli C, Glauser MP.
    Antimicrob Agents Chemother; 1995 Feb 30; 39(2):445-52. PubMed ID: 7726513
    [Abstract] [Full Text] [Related]

  • 25. Empiric treatment of infections in granulocytopenic patients with acute leukemia: a study on amikacin-carbenicillin-cotrimoxazole.
    Cortelezzi A, Radaelli F, Penagini R, Pogliani EM.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 30; 20(11):520-3. PubMed ID: 6983502
    [Abstract] [Full Text] [Related]

  • 26. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA, Wade JC, Schimpff SC, Newman KA, Finley RS, Salvatore PC, Moody MR, Standiford HC, Fortner CL, Wiernik PH.
    Am J Med; 1982 Jul 30; 73(1):89-96. PubMed ID: 6211981
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A, Lim YS, Zulkifli SZ, Zarina AL, Nordiah AJ, Jamal R.
    Singapore Med J; 2007 Jul 30; 48(7):615-9. PubMed ID: 17609821
    [Abstract] [Full Text] [Related]

  • 31. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC.
    Am J Med; 1986 May 30; 80(5C):13-20. PubMed ID: 3521270
    [Abstract] [Full Text] [Related]

  • 32. Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
    González M, Clavell LA.
    P R Health Sci J; 1987 Apr 30; 6(1):13-5. PubMed ID: 3615796
    [Abstract] [Full Text] [Related]

  • 33. Empirical therapy in febrile granulocytopenic patients.
    Gaya H.
    Eur J Cancer (1965); 1979 Apr 30; 15 Suppl():51-8. PubMed ID: 397061
    [No Abstract] [Full Text] [Related]

  • 34. Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
    Herbrecht R, Blaise D, Espinouse D, Leblond V, Sadoun A, Sauvage C, Cordonnier C, Minozzi C.
    J Chemother; 1995 Jun 30; 7 Suppl 2():103-10. PubMed ID: 8622099
    [Abstract] [Full Text] [Related]

  • 35. A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia.
    Del Favero A, Menichetti F, Martino P, Bucaneve G, Micozzi A, Gentile G, Furno P, Russo D, D'Antonio D, Ricci P, Martino B, Mandelli F, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program.
    Clin Infect Dis; 2001 Oct 15; 33(8):1295-301. PubMed ID: 11565068
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV.
    Cancer; 2003 Sep 01; 98(5):1039-47. PubMed ID: 12942573
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.